Drug · DIN 02273322
APTIVUS
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 31, 2025; first marketed December 1, 2005.
- Drug Identification Number (DIN)
- 02273322
- Company (DIN owner)
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Tipranavir J05AE09
- Class
- Human
- Record last updated
- June 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TIPRANAVIR | 250 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 21, 2005: NOC 7615New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “aptivus”. A notice may cover another product or only some lots: read it to see what it covers.